FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1866186113> ?p ?o ?g. }

• W1866186113 endingPage "e1745" @default.
• W1866186113 startingPage "e1745" @default.
• W1866186113 abstract "Hybrid coronary revascularization (HCR), a new minimally invasive procedure for patients requiring revascularization for multivessel coronary lesions, combines coronary artery bypass grafting (CABG) for left anterior descending (LAD) lesions and percutaneous coronary intervention (PCI) for non-LAD coronary lesions. However, available data related to outcomes comparing the 3 revascularization therapies is limited to small studies.We conducted a search in MEDLINE, EMBASE, and the Cochrane Library of Controlled Trials up to December 31, 2014, without language restriction. A total of 16 randomized trials (n=4858 patients) comparing HCR versus PCI or off-pump CABG (OPCAB) were included in this meta-analysis. The primary outcomes were major adverse cardiac and cerebrovascular events (MACCE), all-cause death, myocardial infarction (MI), cerebrovascular events (CVE), and target vessel revascularization (TVR). Odds ratios (OR) and 95% confidence intervals (CI) were calculated using random-effect and fixed-effect models. Ranking probabilities were used to calculate a summary numerical value: the surface under the cumulative ranking (SUCRA) curve.No significant differences were seen between the HCR and PCI in short term (in hospital and 30 days) with regard to MACCE (odds ratio [OR] = 0.51, 95% confidence interval [CI] 0.00-2.35), all-cause death (OR = 2.09, 95% CI 0.34-7.66), MI (OR = 1.02, 95% CI 0.19-2.95), CVE (OR = 4.45, 95% CI 0.39-19.16), and TVR (OR = 6.99, 95% CI 0.17-39.39). However, OPCAB had lower MACCE than HCR (OR = 0.19, 95% CI 0.00-0.95). In midterm (1 year and 3 year), in comparison with HCR, PCI had higher all-cause death (OR = 5.66, 95% CI 0.00-13.88) and CVE (OR = 4.40, 95% CI 0.01-5.68), and lower MI (OR = 0.51, 95% CI 0.00-2.86), TVR (OR = 0.53, 95% CI 0.05-2.26), and thus the MACCE (OR = 0.51, 95% CI 0.00-2.35). Off-pump CABG presented a better outcome than HCR with significant lower MACCE (OR = 0.17, 95% CI 0.01-0.68). Surface under the cumulative ranking probabilities showed that HCR may be the superior strategy for MVD and LMCA disease when regarded to MACCE (SUCRA = 0.84), MI (SUCRA = 0.76) in short term, and regarded to MACCE (SUCRA = 0.99), MI (SUCRA = 0.94), and CVE (SUCRA = 0.92) in midterm.Hybrid coronary revascularization seemed to be a feasible and acceptable option for treatment of LMCA disease and MVD. More powerful evidences are required to precisely evaluate risks and benefits of the 3 therapies for patients who have different clinical characteristics." @default.
• W1866186113 created "2016-06-24" @default.
• W1866186113 creator A5003566533 @default.
• W1866186113 creator A5018110716 @default.
• W1866186113 creator A5029161654 @default.
• W1866186113 creator A5029442830 @default.
• W1866186113 creator A5031983105 @default.
• W1866186113 creator A5034855917 @default.
• W1866186113 creator A5080071850 @default.
• W1866186113 creator A5087521182 @default.
• W1866186113 date "2015-10-01" @default.
• W1866186113 modified "2023-10-18" @default.
• W1866186113 title "Clinical Outcomes of Revascularization Strategies for Patients With MVD/LMCA Disease" @default.
• W1866186113 cites W1559803676 @default.
• W1866186113 cites W1867987062 @default.
• W1866186113 cites W1978000680 @default.
• W1866186113 cites W2010699829 @default.
• W1866186113 cites W2016963349 @default.
• W1866186113 cites W2022960456 @default.
• W1866186113 cites W2024447884 @default.
• W1866186113 cites W2030116555 @default.
• W1866186113 cites W2048070386 @default.
• W1866186113 cites W2049224276 @default.
• W1866186113 cites W2067594359 @default.
• W1866186113 cites W2071032914 @default.
• W1866186113 cites W2075136461 @default.
• W1866186113 cites W2079374201 @default.
• W1866186113 cites W2083187151 @default.
• W1866186113 cites W2093507839 @default.
• W1866186113 cites W2098674170 @default.
• W1866186113 cites W2098923148 @default.
• W1866186113 cites W2109880181 @default.
• W1866186113 cites W2112113110 @default.
• W1866186113 cites W2116475791 @default.
• W1866186113 cites W2122260622 @default.
• W1866186113 cites W2142438744 @default.
• W1866186113 cites W2144031202 @default.
• W1866186113 cites W2148662135 @default.
• W1866186113 cites W2155160353 @default.
• W1866186113 cites W2164835337 @default.
• W1866186113 cites W2291410973 @default.
• W1866186113 cites W2588681363 @default.
• W1866186113 cites W2991473943 @default.
• W1866186113 cites W3149209040 @default.
• W1866186113 cites W4229983675 @default.
• W1866186113 cites W4292000718 @default.
• W1866186113 cites W80017481 @default.
• W1866186113 doi "https://doi.org/10.1097/md.0000000000001745" @default.
• W1866186113 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4620808" @default.
• W1866186113 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26496289" @default.
• W1866186113 hasPublicationYear "2015" @default.
• W1866186113 type Work @default.
• W1866186113 sameAs 1866186113 @default.
• W1866186113 citedByCount "4" @default.
• W1866186113 countsByYear W18661861132021 @default.
• W1866186113 countsByYear W18661861132022 @default.
• W1866186113 countsByYear W18661861132023 @default.
• W1866186113 crossrefType "journal-article" @default.
• W1866186113 hasAuthorship W1866186113A5003566533 @default.
• W1866186113 hasAuthorship W1866186113A5018110716 @default.
• W1866186113 hasAuthorship W1866186113A5029161654 @default.
• W1866186113 hasAuthorship W1866186113A5029442830 @default.
• W1866186113 hasAuthorship W1866186113A5031983105 @default.
• W1866186113 hasAuthorship W1866186113A5034855917 @default.
• W1866186113 hasAuthorship W1866186113A5080071850 @default.
• W1866186113 hasAuthorship W1866186113A5087521182 @default.
• W1866186113 hasBestOaLocation W18661861131 @default.
• W1866186113 hasConcept C126322002 @default.
• W1866186113 hasConcept C141071460 @default.
• W1866186113 hasConcept C156957248 @default.
• W1866186113 hasConcept C164705383 @default.
• W1866186113 hasConcept C168563851 @default.
• W1866186113 hasConcept C2778213512 @default.
• W1866186113 hasConcept C2779464278 @default.
• W1866186113 hasConcept C2780400711 @default.
• W1866186113 hasConcept C44249647 @default.
• W1866186113 hasConcept C45393284 @default.
• W1866186113 hasConcept C500558357 @default.
• W1866186113 hasConcept C71924100 @default.
• W1866186113 hasConceptScore W1866186113C126322002 @default.
• W1866186113 hasConceptScore W1866186113C141071460 @default.
• W1866186113 hasConceptScore W1866186113C156957248 @default.
• W1866186113 hasConceptScore W1866186113C164705383 @default.
• W1866186113 hasConceptScore W1866186113C168563851 @default.
• W1866186113 hasConceptScore W1866186113C2778213512 @default.
• W1866186113 hasConceptScore W1866186113C2779464278 @default.
• W1866186113 hasConceptScore W1866186113C2780400711 @default.
• W1866186113 hasConceptScore W1866186113C44249647 @default.
• W1866186113 hasConceptScore W1866186113C45393284 @default.
• W1866186113 hasConceptScore W1866186113C500558357 @default.
• W1866186113 hasConceptScore W1866186113C71924100 @default.
• W1866186113 hasIssue "42" @default.
• W1866186113 hasLocation W18661861131 @default.
• W1866186113 hasLocation W18661861132 @default.
• W1866186113 hasLocation W18661861133 @default.
• W1866186113 hasLocation W18661861134 @default.
• W1866186113 hasOpenAccess W1866186113 @default.
• W1866186113 hasPrimaryLocation W18661861131 @default.

• next